Chlorambucil <i>versus</i> observation after anti‐<i>Helicobacter</i> therapy in gastric MALT lymphomas: results of the international randomised LY03 trialBarry W. Hancock, Emanuele Zucca, Robert L. Souhami et al.|British Journal of Haematology|2008Cited by 60
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signatureMichael A. Chapman, Kwee Yong, Jonathan Sive et al.|Blood|2018Cited by 20
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma TrialRakesh Popat, Nicholas Counsell, Ruth de Tute et al.|British Journal of Haematology|2021Cited by 5
Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)Rakesh Popat, Kwee Yong, Neil Rabin et al.|Blood|2014Cited by 1